RZNOMICS Trademark

Trademark Overview


On Friday, November 13, 2020, a trademark application was filed for RZNOMICS with the United States Patent and Trademark Office. The USPTO has given the RZNOMICS trademark a serial number of 79300505. The federal status of this trademark filing is REGISTERED as of Tuesday, December 14, 2021. This trademark is owned by Rznomics Inc.. The RZNOMICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Ophthalmic preparations; pharmaceutical products for the treatment of viral and infectious disease, for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceuticals for the treatment of cancer disease, neurodegenerative disease, neurodevelopmental disorder, eye disease, muscular disease, infectious disease, cardiovascular disease, gastrointestinal disease, blood disease, metabolic disease, immune disease, genetic disease; pharmaceutical preparations acting on the central nervous system for the treatment of dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, neuromuscular disorders, neurodevelopmental disorders, neurovascular disease; anti-cancer preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for the use in hematology; anti-diabetic pharmaceuticals; pharmaceutical products for the treatment of infectious disease; anti-dermoinfectives; pharmaceutical prep...

Research and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous disease; scientific research for medical purposes in the area of cancerous disease; research and development in the fields of pharmaceutical and biotechnology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; pharmaceutical products development; research on the subject of pharmaceuticals; clinical studies of medicines, namely, clinical research in the field of cancer therapy, neurodegenerative disease therapy, neurodevelopmental disorder therapy, eye disease therapy, muscular disease therapy, infectious disease therapy, cardiovascular disease therapy, gastrointestinal disease therapy, blood disease therapy, metabolic disease therapy, immune disease therapy, genetic disease therapy, radiology, chemotherapy; medical research services for assessing the efficiency of pharmaceuticals; pharmaceutical drug development servic...
rznomics

General Information


Serial Number79300505
Word MarkRZNOMICS
Filing DateFriday, November 13, 2020
Status700 - REGISTERED
Status DateTuesday, December 14, 2021
Registration Number6585436
Registration DateTuesday, December 14, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 28, 2021

Trademark Statements


Description of MarkThe mark consists of the stylized wording "RZNOMICS" with "R", "NOM", and "CS" in grey, "Z" in red, and the "I" being formed by a grey, yellow, light grey, and red helix with a red circle forming the dot.
Goods and ServicesOphthalmic preparations; pharmaceutical products for the treatment of viral and infectious disease, for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceuticals for the treatment of cancer disease, neurodegenerative disease, neurodevelopmental disorder, eye disease, muscular disease, infectious disease, cardiovascular disease, gastrointestinal disease, blood disease, metabolic disease, immune disease, genetic disease; pharmaceutical preparations acting on the central nervous system for the treatment of dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, neuromuscular disorders, neurodevelopmental disorders, neurovascular disease; anti-cancer preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for the use in hematology; anti-diabetic pharmaceuticals; pharmaceutical products for the treatment of infectious disease; anti-dermoinfectives; pharmaceutical preparations for the treatment of kidney disease; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations in the nature of autonomic drugs for medical purposes; pharmaceutical products for treating respiratory disease; pharmaceutical preparations for treating epidermal problems; viral vaccines; anti-viral agents, namely, anti-viral disinfectants; pharmaceutical and veterinary preparations for the treatment of cancer disease, neurodegenerative disease, eye disease, muscular disease, infectious disease, cardiovascular disease, gastrointestinal disease, blood disease, metabolic disease, immune disease, genetic disease
Indication of Colors claimedThe color(s) gray, red, yellow and light gray is/are claimed as a feature of the mark.
Goods and ServicesResearch and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous disease; scientific research for medical purposes in the area of cancerous disease; research and development in the fields of pharmaceutical and biotechnology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; pharmaceutical products development; research on the subject of pharmaceuticals; clinical studies of medicines, namely, clinical research in the field of cancer therapy, neurodegenerative disease therapy, neurodevelopmental disorder therapy, eye disease therapy, muscular disease therapy, infectious disease therapy, cardiovascular disease therapy, gastrointestinal disease therapy, blood disease therapy, metabolic disease therapy, immune disease therapy, genetic disease therapy, radiology, chemotherapy; medical research services for assessing the efficiency of pharmaceuticals; pharmaceutical drug development services; scientific research in the field of pharmacy; consultancy pertaining to pharmacology; medicine research, namely, research and development of vaccines and medicines; testing of pharmaceuticals; research in the field of medical products; providing information on the test, inspection, and research of medical products; consultation and providing information in the fields of pharmacology; industrial research in the fields of medicine, health and pharmacology; analysis of human tissues for medical research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 29, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 29, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRznomics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameRznomics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameRznomics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Friday, May 27, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 27, 2022FINAL DISPOSITION PROCESSED
Monday, March 14, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 14, 2021REGISTERED-PRINCIPAL REGISTER
Friday, November 12, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, September 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 28, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 24, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 24, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, August 24, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 24, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, August 24, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 23, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 23, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 23, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 23, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 23, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 23, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, May 23, 2021REFUSAL PROCESSED BY IB
Wednesday, April 28, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 28, 2021REFUSAL PROCESSED BY MPU
Wednesday, April 28, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 27, 2021NON-FINAL ACTION WRITTEN
Saturday, April 24, 2021ASSIGNED TO EXAMINER
Saturday, January 2, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, December 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 24, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB